Cancer Drug May Double As an Arthritis Treatment
Deseret News (Salt Lake City) › March 02, 2006
Linked as:
Summary
WASHINGTON (AP) -- The nation's best-selling cancer drug has won federal approval as a treatment for rheumatoid arthritis patients for whom other, older drugs don't work, Genentech Inc. and Biogen Idec Inc. said Wednesday.
The Food and Drug Administration action comes more than eight years after the agency initially approved Rituxan to treat non- Hodgkin's lymphoma.See the full content of this document
Extract
Cancer Drug May Double As an Arthritis Treatment
The two comp...
See the full content of this document
Sponsored links
